AAAAAA

   
Results: 1-13 |
Results: 13
Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine
Authors: Velders, MP Weijzen, S Eiben, GL Elmishad, AG Kloetzel, PM Higgins, T Ciccarelli, RB Evans, M Man, S Smith, L Kast, WM
Citation: Mp. Velders et al., Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine, J IMMUNOL, 166(9), 2001, pp. 5366-5373
Vaccination of seronegative volunteers with a human immunodeficiency virustype 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines
Authors: Boyer, JD Cohen, AD Vogt, S Schumann, K Nath, B Ahn, L Lacy, K Bagarazzi, ML Higgins, TJ Baine, Y Ciccarelli, RB Ginsberg, RS MacGregor, RR Weiner, DB
Citation: Jd. Boyer et al., Vaccination of seronegative volunteers with a human immunodeficiency virustype 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines, J INFEC DIS, 181(2), 2000, pp. 476-483
Safety and immune responses to a DNA-based human immunodeficiency virus (HIV) type I env/rev vaccine in HIV-infected recipients: Follow-up data
Authors: MacGregor, RR Boyer, JD Ciccarelli, RB Ginsberg, RS Weiner, DB
Citation: Rr. Macgregor et al., Safety and immune responses to a DNA-based human immunodeficiency virus (HIV) type I env/rev vaccine in HIV-infected recipients: Follow-up data, J INFEC DIS, 181(1), 2000, pp. 406-406
Characterization of a new class of DNA delivery complexes formed by the local anesthetic bupivacaine
Authors: Pachuk, CJ Ciccarelli, RB Samuel, M Bayer, ME Troutman, RD Zurawski, DV Schauer, JI Higgins, TJ Weiner, DB Sosnoski, DM Zurawski, VR Satishchandran, C
Citation: Cj. Pachuk et al., Characterization of a new class of DNA delivery complexes formed by the local anesthetic bupivacaine, BBA-BIOMEMB, 1468(1-2), 2000, pp. 20-30
Process development and process validation issues for plasmid DNA vaccines
Authors: Clark, DW Ciccarelli, RB
Citation: Dw. Clark et Rb. Ciccarelli, Process development and process validation issues for plasmid DNA vaccines, BIOTECH & B, 25, 2000, pp. 347-360
Enhancement of cellular immune response in HIV-1 seropositive individuals:A DNA-based trial
Authors: Boyer, JD Chattergoon, MA Ugen, KE Shah, A Bennett, M Cohen, A Nyland, S Lacy, KE Bagarazzi, ML Higgins, TJ Baine, Y Ciccarelli, RB Ginsberg, RS MacGregor, RR Weiner, DB
Citation: Jd. Boyer et al., Enhancement of cellular immune response in HIV-1 seropositive individuals:A DNA-based trial, CLIN IMMUNO, 90(1), 1999, pp. 100-107
Protective immune correlates can segregate by vaccine type in a murine herpes model system
Authors: Sin, JI Ayyavoo, V Boyer, J Kim, J Ciccarelli, RB Weiner, DB
Citation: Ji. Sin et al., Protective immune correlates can segregate by vaccine type in a murine herpes model system, INT IMMUNOL, 11(11), 1999, pp. 1763-1773
Induction of HSV-gD2 specific CD4(+) cells in Peyer's patches and mucosal antibody responses in mice following DNA immunization by both parenteral and mucosal administration
Authors: Shroff, KE Marcucci-Borges, LA de Bruin, SJ Winter, LA Tiberio, L Pachuk, C Snyder, LA Satishchandran, C Ciccarelli, RB Higgins, TJ
Citation: Ke. Shroff et al., Induction of HSV-gD2 specific CD4(+) cells in Peyer's patches and mucosal antibody responses in mice following DNA immunization by both parenteral and mucosal administration, VACCINE, 18(3-4), 1999, pp. 222-230
HIV-1 DNA vaccines and chemokines
Authors: Boyer, JD Kim, J Ugen, K Cohen, AD Ahn, L Schumann, K Lacy, K Bagarazzi, ML Javadian, A Ciccarelli, RB Ginsberg, RS MacGregor, RR Weiner, DB
Citation: Jd. Boyer et al., HIV-1 DNA vaccines and chemokines, VACCINE, 17, 1999, pp. S53-S64
In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model
Authors: Sin, JI Kim, JJ Boyer, JD Ciccarelli, RB Higgins, TJ Weiner, DB
Citation: Ji. Sin et al., In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model, J VIROLOGY, 73(1), 1999, pp. 501-509
Systemic and mucosal immunity is elicited after both intramuscular and intravaginal delivery of human immunodeficiency virus type 1 DNA plasmid vaccines to pregnant chimpanzees
Authors: Bagarazzi, ML Boyer, JD Javadian, MA Chattergoon, MA Shah, AR Cohen, AD Bennett, MK Ciccarelli, RB Ugen, KE Weiner, DB
Citation: Ml. Bagarazzi et al., Systemic and mucosal immunity is elicited after both intramuscular and intravaginal delivery of human immunodeficiency virus type 1 DNA plasmid vaccines to pregnant chimpanzees, J INFEC DIS, 180(4), 1999, pp. 1351-1355
IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4(+) T cell-mediated protective immunity against herpes simplex virus-2 challenge. (vol 162, pg 2912, 1999)
Authors: Sin, JI Kim, JJ Arnold, RL Shroff, KE McCallus, D Pachuk, C McElhiney, SP Wolf, MW Pompa-de Bruin, SJ Higgins, TJ Ciccarelli, RB Weiner, DB
Citation: Ji. Sin et al., IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4(+) T cell-mediated protective immunity against herpes simplex virus-2 challenge. (vol 162, pg 2912, 1999), J IMMUNOL, 163(2), 1999, pp. 1094-1094
IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4(+) T cell-mediated protective immunity against herpes simplex virus-2 challenge
Authors: Sin, JI Kim, JJ Arnold, RL Shroff, KE McCallus, D Pachuk, C McElhiney, SP Wolf, MW Pompa-de Bruin, SJ Higgins, TJ Ciccarelli, RB Weiner, DB
Citation: Ji. Sin et al., IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4(+) T cell-mediated protective immunity against herpes simplex virus-2 challenge, J IMMUNOL, 162(5), 1999, pp. 2912-2921
Risultati: 1-13 |